Swiss agency Moderna has stated it should miss second-quarter supply deadlines for the UK and Canada, however not the EU or Switzerland, Reuters experiences. “Vaccine manufacturing is a extremely advanced course of and numerous components, together with human and materials assets have factored into this volatility,” Patricia Gauthier, a Moderna Canada government stated. The announcement comes amid an ongoing row between the UK and Europe on vaccine shortfalls and exports.